Absence of sarcoplasmic myxovirus resistance protein A (MxA) expression in antisynthetase syndrome in a cohort of 194 cases
Neuropathol Appl Neurobiol
.
2019 Aug;45(5):523-524.
doi: 10.1111/nan.12551.
Epub 2019 May 29.
Authors
M Inoue
1
2
,
J Tanboon
1
2
,
M Okubo
1
2
,
K Theerawat
1
2
,
Y Saito
1
2
,
M Ogasawara
1
2
,
L A Indrawati
1
2
,
A Uruha
3
,
N Okiyama
4
,
M Fujimoto
5
,
S Suzuki
6
,
I Nishino
1
2
Affiliations
1
Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
2
Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan.
3
Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
4
Department of Dermatology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
5
Department of Dermatology, Graduate School of Medicine, Osaka University, Osaka, Japan.
6
Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
PMID:
30959571
DOI:
10.1111/nan.12551
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Cohort Studies
Dermatomyositis*
Humans
Myositis
Orthomyxoviridae*
Staphylococcal Protein A
Substances
Staphylococcal Protein A
Supplementary concepts
Antisynthetase syndrome